
We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms
Unlock the market timeline & signal feed
New Footprint activity — 3 fresh signals just appeared.
The order this company entered each market — oldest to newest
Environmental Monitoring Expert - Pharma
62 active postings
Sign up to see the full signal feed
How Sanofi's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
SanofiYou | 41 | 0 | -56% | 204 | 36 |
Global Category Buyer External Manufacturing
View postingBarcelona, Catalonia, Spain · yesterday
AI Engineer
View postingBarcelona, Catalonia, Spain · yesterday
People Services Senior Generalist
View postingPetaling Jaya, Selangor, Malaysia · yesterday
Vores miljøindsats bygger på målbare fremskridt 🌱På årets #WorldEnvironmentDay sætter vi fokus på, hvordan vi har omsat ambitioner til handling 🌍I løbet af 2025 har vi:✔ Reduceret vores drivhusgasudledning med 18 % de seneste seks år✔ Sikret, at 100 % af vores nye lægemidler og vacciner lever op til økodesignprincipper✔ Drevet 85 % af vores aktiviteter med vedvarende elektricitet✔ Genbrugt, genanvendt eller nyttiggjort 89 % af vores affald✔ Sænket vores ferskvandsforbrug med 29 %✔ Fået tildelt ...
EndedYou are a HCP, do you want to be empowered?
Active🎧 Listen now!
EndedAI coding startup Cursor opens European headquarters in London, planning to hire 200 staff. SpaceX holds $60 billion acquisition option. Company has $2.6 billion annualized B2B revenue.
SK Bioscience acquires 390,000 treasury shares (0.5% of total) for employee compensation through RSU program, requiring 3-year service commitment to align long-term growth with employee rewards.
The 28th China Beijing International High-Tech Expo will be held May 8-10, 2026, featuring an immersive AI experience zone with participation from multinational corporations and innovative enterprises showcasing cutting-edge technologies.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Sanofi's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.